The minister was responding to a question on whether state governments are following herd immunity measures. Trying to develop herd immunity against COVID-19 in the absence of established pharmaceutical interventions may have disastrous consequences in terms of morbidity and mortality, Rajya Sabha was told. The minister was responding to a question on whether state governments are following herd immunity measures to fight the COVID-19 pandemic in the country. “Development of herd immunity essentially means allowing the virus to run through the population. Thirteen clinical trials of repurposed drugs have been undertaken to build a portfolio of therapeutic options for COVID-19 patients, Mr. Choubey said.

Source: The Hindu September 20, 2020 08:01 UTC